RE:RE:RE:RE:Q2 2022...Let's do own prelim guidance...Purportedly some US buying has come into IPO which according to todays S.A. article by investment Dr. is related to their superior US "listing" vs. other Cdn. juniors which might result in a higher valuation. The company does market in the U.S.